| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 15, 2010Safety and Effectiveness Trial Evaluated the Arctic Front(R) Cardiac CryoAblation Catheter System for the Treatment of Paroxysmal Atrial Fibrillation
MINNEAPOLIS & ATLANTA, Mar 15, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced data from the STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial...
-
Mar 14, 2010Independent Analysis of Large and Comprehensive ENDEAVOR Program Shows Remarkably Durable Safety and Efficacy at Five Years of Follow Up in Coronary Artery Disease Patients
MINNEAPOLIS & ALTANTA, Mar 14, 2010 (BUSINESS WIRE) -- The consistency and quality of the long-term clinical results for the Endeavor(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT),...
-
Mar 12, 2010Post-Market Evaluation of Breakthrough Medical Device Begins Enrolling Patients; First Implants Occur in Germany
MINNEAPOLIS, Mar 12, 2010 (BUSINESS WIRE) -- Moving to expand the evidence base for the future of structural heart disease therapy,Medtronic, Inc. (NYSE: MDT), today announced the start of the...
-
Mar 12, 2010
MINNEAPOLIS, Mar 12, 2010 (BUSINESS WIRE) -- The U.S. Food and Drug Administration (FDA) Neurological Devices Panel today voted seven to five to recommend approval with conditions of Deep Brain...
-
Mar 11, 2010
MINNEAPOLIS, Mar 11, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced a registered offering of $1.25 billion of its 3.0 percent Senior Notes due 2015, $1.25 billion of its 4.45...